beta-lactams has been researched along with Acute Lymphoid Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; He, W; Li, H; Liu, J; Wang, H; Wang, Q; Wang, X; Wang, Z; Zhang, F; Zhang, Y; Zhao, C | 1 |
| Arefi, H; Pirahmadi, N; Pourahmad, J; Salimi, A; Zarghi, A | 1 |
2 other study(ies) available for beta-lactams and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Novel NDM-9 metallo-β-lactamase identified from a ST107 Klebsiella pneumoniae strain isolated in China.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Child; China; Gene Expression; Humans; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2014 |
β-lactam Structured, 4-(4-(Methylsulfonyl)phenyl)-1-pentyl-3-phenoxyazetidin-2-one: Selectively Targets Cancerous B Lymphocyte Mitochondria.
Topics: Antineoplastic Agents; Azetines; B-Lymphocytes; beta-Lactams; Cell Proliferation; Child; Child, Preschool; Cytochromes c; Cytosol; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Male; Mitochondria; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Reactive Oxygen Species; Structure-Activity Relationship | 2017 |